ALZN logo

Alzamend Neuro, Inc. (ALZN)

Profile

Full Name

Alzamend Neuro, Inc.

Ticker

NASDAQ: ALZN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 15, 2021

Indexes

Not included

Website

https://www.alzamend.com

Employees

4

Key Details

Price

$2.28(+0.88%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$11.32(+22.99% YoY)

PE ratio

-

Next earnings date

Sep 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.28
    ALZN price is $2.28

    30-Day Relative Volume

    1.05
    ALZN 30-day relative volume is 1.05

    Price Performance

    Price Today change

    +0.88%
    ALZN price is up +0.88% today

    Price YTD change

    -78.16%
    ALZN price is down -78.16% since January 1st

    Price 1-year change

    -94.18%
    ALZN price is down -94.18% year-on-year

    Price 3-year change

    -99.83%
    ALZN price is down -99.83% over the past 3 years

    Price Range

    Price All-time high

    $45.29K
    ALZN price is currently -99.99% below its historical high of $45.29 thousand

    Price 3-year low

    $2.06
    ALZN price is currently +10.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.16M
    ALZN market capitalization is $7.16 million

    Market cap 3-year change

    -92.65%
    ALZN market capitalization is down -92.65% over the past 3 years

    Market cap All-time high

    $1.15B
    ALZN market capitalization is currently -99.38% below its historical high of $1.15 billion

    Market cap sector rank

    13.02%
    ALZN market capitalization is higher than 13.02% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3180.98%
    ALZN shares outstanding is up +3180.98% year-on-year

    Shares Outstanding 3-Year Change

    +4341.16%
    ALZN shares outstanding is up +4341.16% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.18
    ALZN beta is 0.18

    200-day SMA

    $7.27
    ALZN price is currently -68.64% below its 200-day simple moving average

    50-day SMA

    $2.83
    ALZN price is currently -19.52% below its 50-day simple moving average

    RSI

    33.90
    ALZN 14-day relative strength index is 33.90

    Volume

    1.05
    ALZN 30-day relative volume is 1.05

    ATR

    $0.15
    ALZN average true range is $0.15

    10-day Historical Volatility

    36.26%
    ALZN 10-day historical volatility is 36.26%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ALZN annual revenue is $0.00

    Revenue Analysts estimate

    -
    ALZN annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ALZN annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.61%
    ALZN annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    -$11.32
    ALZN annual earnings per share is -$11.32

    EPS Analysts estimate

    -$10.98
    ALZN annual earnings per share is currently +3.10% higher than the consensus analysts' forecast

    EPS 1-year change

    +22.99%
    ALZN annual earnings per share is up +22.99% year-on-year

    EPS Sector rank

    12.12%
    ALZN annual earnings per share is higher than 12.12% of companies in Healthcare sector

    Profit

    Gross profit

    -$50.70K
    ALZN annual gross profit is -$50.70 thousand

    Gross margin

    -
    ALZN annual gross profit margin value is unknown

    Operating profit

    -$4.50M
    ALZN annual operating income is -$4.50 million

    Operating margin

    -
    ALZN annual operating profit margin value is unknown

    Net income

    -$4.51M
    ALZN annual net profit is -$4.51 million

    Net margin

    -
    ALZN annual net profit margin value is unknown

    Expenses

    Total expenses

    $4.51M
    ALZN annual total expenses is $4.51 million

    Operating expenses

    $4.45M
    ALZN annual total operating expenses is $4.45 million

    Cost of goods sold

    $50.70K
    ALZN annual cost of goods sold is $50.70 thousand

    Selling, general & administrative expenses

    $0.00
    ALZN annual SGA is $0.00

    Depreciation and amortization

    $50.70K
    ALZN annual depreciation & amortization is $50.70 thousand

    Interest expense

    $0.00
    ALZN annual interest expense is $0.00

    Income tax

    $0.00
    ALZN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$4.50M
    ALZN annual earnings before interest & taxes is -$4.50 million

    EBITDA

    -$4.45M
    ALZN annual EBITDA is -$4.45 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.60M
    ALZN annual total assets is $4.60 million

    Non current assets

    $425.60K
    ALZN annual long term assets is $425.60 thousand

    Current assets

    $4.18M
    ALZN annual total current assets is $4.18 million

    Cash and cash equivalents

    $3.95M
    ALZN annual cash & cash equivalents is $3.95 million

    Accounts receivable

    -
    ALZN annual accounts receivable value is unknown

    Inventory

    $0.00
    ALZN annual inventory is $0.00

    Liabilities

    Total liabilities

    $634.80K
    ALZN annual total liabilities is $634.80 thousand

    Long term liabilities

    $0.00
    ALZN annual total long term liabilities is $0.00

    Current liabilities

    $634.80K
    ALZN annual total current liabilities is $634.80 thousand

    Accounts payable

    $0.00
    ALZN annual accounts payable is $0.00

    Debt

    Total debt

    $0.00
    ALZN annual total debt is $0.00

    Total debt 1-year change

    -100%
    ALZN annual total debt is down -100% year-on-year

    Long term debt

    $0.00
    ALZN annual long term debt is $0.00

    Short term debt

    $0.00
    ALZN annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $3.97M
    ALZN annual stockholders equity is $3.97 million

    Book value

    $3.97M
    ALZN annual book value is $3.97 million

    Retained earnings

    -$58.54M
    ALZN annual retained earnings is -$58.54 million

    Working capital

    $3.54M
    ALZN annual working capital is $3.54 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$6.57M
    ALZN annual cash flow from operations is -$6.57 million

    Cash from operations 1-year change

    +20.58%
    ALZN annual cash flow from operations is up +20.58% year-on-year

    Cash from investing

    -$300.00K
    ALZN annual cash flow from investing activities is -$300.00 thousand

    Cash from investing 1-year change

    -103.8%
    ALZN annual cash flow from investing activities is down -103.8% year-on-year

    Cash from financing

    $10.44M
    ALZN annual cash flow from financing activities is $10.44 million

    Cash from financing 1-year change

    +185.86%
    ALZN annual cash flow from financing activities is up +185.86% year-on-year

    CAPEX

    CAPEX

    $300.00K
    ALZN annual capital expenditures is $300.00 thousand

    CAPEX 1-year change

    +103.8%
    ALZN annual capital expenditures is up +103.8% year-on-year

    Free Cash Flow

    Free cash flow

    -$6.87M
    ALZN annual free cash flow is -$6.87 million

    Free cash flow 1-year change

    +18.4%
    ALZN annual free cash flow is up +18.4% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ALZN annual gross profit margin value is unknown

    Operating margin

    -
    ALZN annual operating profit margin value is unknown

    Net margin

    -
    ALZN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -172.50%
    ALZN annual return on assets is -172.50%

    ROE

    -657.19%
    ALZN annual return on equity is -657.19%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ALZN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ALZN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.80
    ALZN price to book ratio is 1.80

    PB ratio Sector rank

    52.29%
    ALZN price to book ratio is higher than 52.29% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ALZN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ALZN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $3.21M
    ALZN enterprise value is $3.21 million

    Enterprise value Sector rank

    16.74%
    ALZN enterprise value is higher than 16.74% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.72
    ALZN EV/EBITDA is -0.72

    EV/EBITDA Sector rank

    50.27%
    ALZN EV/EBITDA is higher than 50.27% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.58
    ALZN annual current ratio is 6.58

    Quick ratio

    6.58
    ALZN annual quick ratio is 6.58

    Leverage

    Debt to equity

    0.00
    ALZN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ALZN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ALZN piotroski f-score value is unknown

    Altman Z-Score

    -13.34
    ALZN altman z-score is -13.34

    Analyst ratings

    Recent major analysts updates

    Mar 17, 25 Ascendiant Capital
    Buy
    Dec 16, 24 Ascendiant Capital
    Buy
    Nov 11, 24 Ascendiant Capital
    Buy
    Apr 12, 23 Maxim Group
    Buy
    Oct 1, 21 Ascendiant Capital
    Buy

    Institutional Ownership

    Screeners with ALZN included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Alzamend Neuro, Inc.?
    • Does Alzamend Neuro, Inc. pay dividends?
    • What sector is Alzamend Neuro, Inc. in?
    • What industry is Alzamend Neuro, Inc. in?
    • What country is Alzamend Neuro, Inc. based in?
    • When did Alzamend Neuro, Inc. go public?
    • Is Alzamend Neuro, Inc. in the S&P 500?
    • Is Alzamend Neuro, Inc. in the NASDAQ 100?
    • Is Alzamend Neuro, Inc. in the Dow Jones?
    • When was Alzamend Neuro, Inc.'s last earnings report?
    • When does Alzamend Neuro, Inc. report earnings?

    What is the ticker symbol for Alzamend Neuro, Inc.?

    The ticker symbol for Alzamend Neuro, Inc. is NASDAQ:ALZN

    Does Alzamend Neuro, Inc. pay dividends?

    No, Alzamend Neuro, Inc. does not pay dividends

    What sector is Alzamend Neuro, Inc. in?

    Alzamend Neuro, Inc. is in the Healthcare sector

    What industry is Alzamend Neuro, Inc. in?

    Alzamend Neuro, Inc. is in the Biotechnology industry

    What country is Alzamend Neuro, Inc. based in?

    Alzamend Neuro, Inc. is headquartered in United States

    When did Alzamend Neuro, Inc. go public?

    Alzamend Neuro, Inc.'s initial public offering (IPO) was on June 15, 2021

    Is Alzamend Neuro, Inc. in the S&P 500?

    No, Alzamend Neuro, Inc. is not included in the S&P 500 index

    Is Alzamend Neuro, Inc. in the NASDAQ 100?

    No, Alzamend Neuro, Inc. is not included in the NASDAQ 100 index

    Is Alzamend Neuro, Inc. in the Dow Jones?

    No, Alzamend Neuro, Inc. is not included in the Dow Jones index

    When was Alzamend Neuro, Inc.'s last earnings report?

    Alzamend Neuro, Inc.'s most recent earnings report was on March 10, 2025

    When does Alzamend Neuro, Inc. report earnings?

    The next expected earnings date for Alzamend Neuro, Inc. is September 11, 2025
    On this page